CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Palliative and Supportive Care

ONCOLOGY. Vol. 17 No. 4
 

Commentary (Bouda)—Opioids in Cancer Pain: Common Dosing Errors

The Kochhar/LeGrand/Walsh et al Article Reviewed

By David W. Bouda, MD1 | April 1, 2003
1Associate Professor Section of Oncology/Hematology, Department of Internal Medicine, Director, Lifestyle Enhancement Center, University of Nebraska Medical Center, Omaha, Nebraska

I read with pleasure this article from the staff of the Harry R. Horvitz Center for Palliative Medicine, an institution with expertise and experience to draw upon. All multidisciplinary cancer centers should have an expertise in palliative medicine if not a formalized program, as one of the most important jobs of oncologists is to relieve pain and suffering for patients and their families. When pain is effectively addressed, the patient's aggregate quality of life is optimized and time spent with family and friends is more enjoyable.

To accomplish this goal requires not only knowledge but a sense of collegial connectedness and the willingness to refer to those interested in pain management-ie, to escape the hubris that one oncologist can know all. If we have oncology subspecialization in disease treatment and research, pain management deserves a role as prominent as that of the lymphoma expert.

Tailored Approach Needed

(MORE: Opioids in Cancer Pain: Common Dosing Errors)

The relief of pain requires a timeintense individualized approach that is often contrary to the requirements of clinical studies, translational research, and managed care time restraints. Despite the existence of validated World Health Organization (WHO) guidelines, their application is spotty, and an understanding of WHO guidelines is often assumed rather than carefully taught.

The clear identification of pain as either (1) constant, (2) incidental, or (3) breakthrough gives an excellent stratification with which to address the concepts of (1) strategy, (2) titration, and (3) conversion. The authors' clearly discussed 11 errors offer a succinct approach to addressing these items.

The number 1 job in oncologic pain management is to avoid rescue or prn dosing, as this is the surest way to create dependence, decrease quality of life, and promote drug-seeking behavior. All too often we approach the management of pain in cancer patients in the same way we approach pain in the patient with a broken ankle. Cancer pain is not going away anytime soon, is unlikely to be relieved by positioning, and, in a terminal condition, is likely to be exacerbated by emotional components.

To start a patient on immediaterelease medicine around the clock is acceptable, but in a cancer patient we need to address the persistent nature of pain and focus on sustained-release medications, with immediate-release agents reserved for breakthrough episodes. Another issue that is often overlooked in this setting is incident pain. If we wish the highest quality of life for our patients, then we need to find unique ways for them to perform their activities of daily living and have pain-free periods in which to interact with their families. Taking a bath/ shower, shaving, dressing, defecating, or riding in a car should not be negative experiences with good clinical practice.

Adjuvant medications are discussed briefly and appropriately, but I would add that a panoply of nonpharmacologic adjuvant analgesic options are available that physicians do not think about. These include modalities such as massage, triggerpoint release, gentle relaxation yoga, and acupuncture. Such options should be explored so that the medication load and its potential side effects are kept to a minimum. We do not need polypharmacy and its attendant complications and side effects to lessen the quality of the patient's remaining time.

A Physician's Touch

The effort to provide appropriate dosing time intervals, utilize equianalgesic medications, and pay attention to the pain stratification of constant, incident, and breakthrough pain requires a physician's touch. This most important part of patient care cannot be delegated or relegated to health-care extenders. Physician involvement is paramount in an effective palliative and analgesic program.

The physician and patient must create a therapeutic relationship that is effective in pain management and complementary to conventional pain management approaches as well as nonpharmacologic analgesic activities. This takes time, and the cognitive and empathetic interaction should be rewarded appropriately and without distasteful health-care management interference.

Finally, I think directors of oncology fellowships, and directors of internal medicine residencies should compile the excellent 20 references identified by Kochhar et al along with this article and local favorites to be read by all their students. A champion for pain management or palliative medicine should be identified and supported by each institution, whether an academic or community facility. No patient's pain should be ignored.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

This commentary refers to the following article

Opioids in Cancer Pain: Common Dosing Errors



ROMEEN KOCHHAR, MD, SUSAN B LEGRAND, MD, FACP, DECLAN WALSH, MSc, FACP, FRCP (Edin), MELLAR P. DAVIS, MD, FCCP, RUTH LAGMAN, MD and NILO I. RIVERA, MD



 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Palliative And Supportive Care
Evidence on Palliative And Supportive Care
Guidelines on Palliative And Supportive Care
Patient Education on Palliative And Supportive Care
Clinical Trials on Palliative And Supportive Care
Practical Articles on Palliative And Supportive Care
Research and Reviews on Palliative And Supportive Care
All "Palliative And Supportive Care" results



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy